These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26606524)

  • 1. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
    Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
    Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study.
    Goules AV; Chatzis L; Pezoulas VC; Patsouras M; Mavragani C; Quartuccio L; Baldini C; De Vita S; Fotiadis DI; Tzioufas AG
    Lancet Rheumatol; 2024 Oct; 6(10):e693-e702. PubMed ID: 39182505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
    Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
    J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
    Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
    Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome.
    Tomi AL; Belkhir R; Nocturne G; Desmoulins F; Berge E; Pavy S; Miceli-Richard C; Mariette X; Seror R
    Arthritis Rheumatol; 2016 May; 68(5):1245-50. PubMed ID: 26636425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
    Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome.
    Tzioufas AG; Boumba DS; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 1996 May; 39(5):767-72. PubMed ID: 8639173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.
    Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Rönnblom L; Sundström C; Baecklund E
    Scand J Rheumatol; 2020 May; 49(3):225-232. PubMed ID: 32153241
    [No Abstract]   [Full Text] [Related]  

  • 9. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
    Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study.
    Rocca J; Beydon M; Le Guern V; Hachulla E; Couderc M; Jousse-Joulin S; Devauchelle-Pensec V; Gottenberg JE; Vittecoq O; Lavigne C; Schmidt J; Larroche C; Mariette X; Seror R; Nocturne G
    Lancet Rheumatol; 2024 Oct; 6(10):e703-e712. PubMed ID: 39182508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
    Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
    Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting lymphoma development in patients with Sjögren's syndrome.
    De Vita S; Gandolfo S
    Expert Rev Clin Immunol; 2019 Sep; 15(9):929-938. PubMed ID: 31347413
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981-2021).
    Chatzis LG; Stergiou IE; Goules AV; Pezoulas V; Tsourouflis G; Fotiadis D; Tzioufas AG; Voulgarelis M
    Rheumatology (Oxford); 2022 Aug; 61(9):3576-3585. PubMed ID: 34940812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
    Fabris M; Dolcetti R; Pasini E; Quartuccio L; Pontarini E; Salvin S; Ponzoni M; Scott CA; De Vita S
    Clin Exp Rheumatol; 2014; 32(1):61-5. PubMed ID: 24447326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoproliferative disorders in Sjögren's syndrome].
    Prochorec-Sobieszek M; Wagner T
    Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome.
    Yachoui R; Leon C; Sitwala K; Kreidy M
    Clin Med Res; 2017 Jun; 15(1-2):6-12. PubMed ID: 28487450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
    Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
    Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.